Clinical trials
Terminated Phase 1 trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Ferring Pharmaceuticals | 2 |
| Incyte Corporation | 2 |
| Norwegian University of Science and Technology | 2 |
| Novartis Pharmaceuticals | 2 |
| Bayer | 1 |
| BerGenBio ASA | 1 |
| Biotec Pharmacon ASA | 1 |
| Bioverativ, a Sanofi company | 1 |
| Blueprint Medicines Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Myelodysplastic Syndromes | 2 |
| Neoplasms | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Anus Neoplasms | 1 |
| Basal Cell Carcinoma | 1 |
| Burns | 1 |
| Carcinoma, Merkel Cell | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.